Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany

Infection

Volumn 43, Issue 1, 2015, Pages 45-50

  Borde, J P ^a   Litterst, S ^c   Ruhnke, M ^a   Feik, R ^a   Hubner J ^d   deWith, K ^e   Kaier, K ^b   Kern, W V ^b  

^a Medizinische Klinik   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Zentralapotheke des Ortenau Klinikums Offenburg Gengenbach   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Antibiotic stewardship; Cephalosporins; Community non teaching hospital; Fluoroquinolones; Interrupted time series analysis; Secondary setting

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; GLYCOPEPTIDE; MACROLIDE; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC STEWARDSHIP PROGRAM; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLOSTRIDIUM DIFFICILE INFECTION; DRUG LEGISLATION; DRUG TARGETING; DRUG USE; GERMANY; HEALTH PROGRAM; HOSPITAL BED CAPACITY; HOSPITAL INFECTION; HUMAN; INCIDENCE; LENGTH OF STAY; PRESCRIPTION; TIME SERIES ANALYSIS; ANTIBIOTIC RESISTANCE; COMMUNITY HOSPITAL; CROSS INFECTION; HOSPITAL PHARMACY; ORGANIZATION AND MANAGEMENT; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GERMANY; HOSPITALS, COMMUNITY; HUMANS; INCIDENCE; INTERRUPTED TIME SERIES ANALYSIS; PHARMACY SERVICE, HOSPITAL; PRESCRIPTIONS;

EID: 84925481625     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-014-0693-2     Document Type: Article

References (23)

1. Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2013;41:137–42.
2. Livermore DM, Hope R, Reynolds R, Blackburn R, Johnson AP, Woodford N. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?. Chemother: J. Antimicrob; 2013.
3. Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Darwish Elhajji FW et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br. J. Clin. Pharmacol. 2012;74:171–9.
4. Petrikkos G, Markogiannakis A, Papaparaskevas J, Papapareskevas J, Daikos GL, Stefanakos G, et al. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospita. Agents: Int. J. Antimicrob; 2007.
5. LeBlanc L, Pépin J, Toulouse K, Ouellette M-F, Coulombe M-A, Corriveau M-P, et al. Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus. Canada. Emerg. Infect. Dis. 2006;12:1398–405.
6. Kaier K, Hagist C, Frank U, Conrad A, Meyer E. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Epidemiol: Infect. Control Hosp; 2009.
7. Pépin J, Saheb N, Coulombe M-A, Alary M-E, Corriveau M-P, Authier S et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin. Infect. Dis. [Internet]. 2005;41:1254–60.
8. Talpaert MJ. Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011;66:2168–74.
9. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance 2001 to 2008. Crit Care. 2010;14:R113.
10. Mondain V, Lieutier F, Hasseine L, Gari-Toussaint M, Poiree M, Lions C, et al. A 6-year antifungal stewardship programme in a teaching hospital. Infection. 2013;41:621–8.
11. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein R a, Burke JP et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 2007;44:159–77.
12. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane database Syst. Rev. 2013 4:CD003543.
13. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72.
14. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.
15. Borde JP, Batin N, Rieg S, Feik R, Reimling C, Kern WV et al. Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital. Infection 2014.
16. Schmitt S, McQuillen DP, Nahass R, Martinelli L, Rubin M, Schwebke K, et al. Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Dis: Clin. Infect; 2014.
17. Borde JP, Kaier K, Steib-Bauert M, Vach W, Geibel-Zehender A, Busch H, et al. Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center. BMC Infect Dis. 2014;14:201.
18. Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. Chemother: J. Antimicrob; 2014.
19. http://www.who.int/drugresistance/en/.
20. S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus AWMF-Registernummer 092/001, 2013.
21. http://www.nrz-hygiene.de/surveillance/kiss/cdad-kiss/.
22. http://www.antiinfektiva-surveillance.de/32-0-Allgemeine-Informationen.html.
23. https://influenza.rki.de/Diagrams.aspx?agiRegion=0.